Cord Blood News Volume 3.09 | Mar 10 2011

 Cell Therapy News is now on Facebook. Join us!

 Follow us on Twitter!  @Cord_Blood_News

Interested in recruiting talented individuals? Post your career opportunities in Cord Blood News at no cost. Contact us at info@connexoncreative.com

HHV-6 Reactivation and Its Effect on Delirium and Cognitive Functioning in Hematopoietic Cell Transplant Recipients
Patients with HHV-6 were more likely to develop delirium (adjusted odds ratio (aOR) 2.5; 95% confidence interval (CI) 1.2-5.3) and demonstrate neurocognitive decline (aOR 2.6; 95% CI 1.1-6.2) in the first 84 days post hematopoietic cell transplantation. Cord blood and unrelated transplantation increased risk of HHV-6 reactivation. [Blood]

Amniotic Liquid Derived Stem Cells as Reservoir of Secreted Angiogenic Factors Capable of Stimulating Neo-Arteriogenesis in an Ischemic Model
Researchers used human amniotic fluid stem cells (AFSC) to evoke a strong angiogenic response in murine recipients, in terms of host guided-regeneration of new vessels, and we demonstrated that the AFSC secretome is responsible for the vascularizing properties of these cells. [Biomaterials]

The Treatment of Neurodegenerative Disorders Using Umbilical Cord Blood and Menstrual Blood-Derived Stem Cells
Mononuclear umbilical cord blood cells and menstrual blood-derived stem cells, particularly umbilical cord blood cells, have been studied as either single or multiple injections in a number of animal models of neurodegenerative disorders with some degree of success, including stroke, Alzheimer’s disease, amyotrophic lateral sclerosis, and Sanfilippo syndrome type B. [Cell Transplant]

MMP-2 Mediates Mesenchymal Stem Cell Tropism Towards Medulloblastoma Tumors
Researchers conclude that human umbilical cord blood-derived stem cells can integrate into human medulloblastoma after local delivery and that matrix metalloproteinase (MMP)-2 expression by the tumor cells mediates this response through the stromal cell-derived factor 1/CXCR4 axis. [Gene Ther]

Unrelated Cord Blood Transplantation for Thalassemia: A Single-Institution Experience of 35 Patients
Data compare acceptably with the survival rates of related-donor BMT for thalassemia and suggest that patients without an available HLA-compatible sibling but who have well-matched unrelated donors should also be considered for cord blood transplantation. [Bone Marrow Transplant]

Identification and Frequency of CCR5Δ32/Δ32 HIV-Resistant Cord Blood Units from Houston Area Hospitals
Routine genotyping to identify HIV-resistant cord blood (CB) units could create a bank of CB-derived stem/progenitor cells with which to treat HIV infection. [HIV Med]

Successful Treatment with Combined Chemotherapy of Two Adult Cases of Hemophagocytic Lymphohistiocytosis in Recipients of Umbilical Cord Blood Cell Transplantation
The combined use of low-dose etoposide and vincristine plus prednisolone appears to be a promising treatment option for hematopoietic stem cell transplantation-hemophagocytic lymphohistiocytosis, without serious adverse side effects. [Int J Hematol]

MARCH-I Expression in Cord Blood CD34+KDR+ Cells
MARCH-I expression in stem cells could be important for their intrinsic immune properties. [Clin Biochem]

The Preparation and Storage of Dried-Blood Spot Quality Control Materials for Lysosomal Storage Disease Screening Tests
Umbilical-cord blood is the preferred matrix for lysosomal storage disease-normal dried-blood spot quality control materials. [Clin Biochem]

Delivery of Fibroblast Growth Factor 2 Enhances the Viability of Cord Blood-Derived Mesenchymal Stem Cells Transplanted to Ischemic Limbs
Researchers hypothesized that local delivery of fibroblast growth factor 2 to the site of cord blood-derived mesenchymal stem cell (CBMSC) transplantation would enhance the viability of CBMSCs transplanted to ischemic tissues. [J Biosci Bioeng]

Miriam Gonzalez Calls for Investment into Cord Blood
Miriam Gonzalez, wife of Deputy Prime Minister Nick Clegg, hosted her first political reception in aid of Anthony Nolan, to raise awareness about cord blood. [The Anthony Nolan Trust Press Release]

NEW International Conference and Exhibition on Cancer Science & Therapy
August 15-17, 2011
Las Vegas, United States

NEW Adult MSC2011: Innovations in Cell-Based Regenerative Therapies
August 22-24, 2011
Cleveland, United States

Visit our events page to see a complete list of events in the cord blood community.

Implementation Coordinator – Maternity Leave Contract (STEMSOFT Software Inc.)

Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

Cell Therapy Manufacturing Manager (Opexa Therapeutics)

Postdoctoral Fellow (The Henry M. Jackson Foundation)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with the Connexon Creative Job Board at no cost.

Visit here to post your career opportunities.

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or Suggestions? Email info@connexoncreative.com with your feedback.